دورية أكاديمية
أعرض في EDS

Evaluation of the prevalence of asthma and chronic obstructive pulmonary disease among opium users, and cigarette smokers and comparison with normal population in Kharameh: a cross-sectional study.

التفاصيل البيبلوغرافية
العنوان: Evaluation of the prevalence of asthma and chronic obstructive pulmonary disease among opium users, and cigarette smokers and comparison with normal population in Kharameh: a cross-sectional study.
المؤلفون: Raeisy L; Student Research committee of medical school, Shiraz University of Medical Sciences, Shiraz, Iran., Masoompour SM; Non-Communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. masoomm@sums.ac.ir., Rezaianzadeh A; Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
المصدر: BMC pulmonary medicine [BMC Pulm Med] 2023 Nov 01; Vol. 23 (1), pp. 419. Date of Electronic Publication: 2023 Nov 01.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968563 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2466 (Electronic) Linking ISSN: 14712466 NLM ISO Abbreviation: BMC Pulm Med Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : BioMed Central, [2001]-
مواضيع طبية MeSH: Opium Dependence* , Asthma*/epidemiology , Pulmonary Disease, Chronic Obstructive*/epidemiology , Tobacco Products*, Humans ; Middle Aged ; Aged ; Cross-Sectional Studies ; Opium ; Prevalence ; Smokers ; Forced Expiratory Volume ; Vital Capacity
مستخلص: Background: Recent studies have suggested that opium use may increase mortality from pulmonary diseases. However, there are limited comprehensive studies regarding the prevalence of Asthma and Chronic Obstructive Pulmonary Disease (COPD) among tobacco and opium users has been published. We aimed to determine the prevalence of respiratory disease among tobacco and opium users.
Methods: This cross-sectional study of tobacco and opium users and matched controls was conducted in the Kharameh Cohort, Fars, Iran. The prevalence of COPD and asthma, along with the participants demographical and spirometry data were examined.
Results: The average age of participants was 57 ± 8 years. Never smokers had a significant higher BMI (26.6 vs. 24.8), FEV1 (91% vs. 82%) and FVC (96% vs. 88%) values compared to participants with a positive smoking status. There was a statistical difference in the prevalence of COPD, asthma, and asthma COPD overlap (ACO) based on the participants smoking status, with the highest prevalence among opium and cigarette smokers, followed by opium users alone. Based on multivariate analysis, higher age, lower BMI, lower education than under diploma, cigarette smoking and opium use were significantly correlated with higher COPD prevalence; while lower age, cigarette smoking and opium use were significantly correlated with higher asthma prevalence. Illiterate participants had a significantly higher prevalence of COPD (23.6%), asthma (22%), and ACO (7.9%) among the educational groups. Regarding the prevalence of asthma, the higher socio-economic group had the lowest prevalence.
Conclusions: Opium and tobacco users had a significantly higher prevalence of respiratory diseases, along with lower lung function tests based on spirometry evaluation.
(© 2023. The Author(s).)
References: J Prev Med Hyg. 2021 Jan 14;61(4):E578-E583. (PMID: 33628964)
Chest. 2005 Oct;128(4):1951-7. (PMID: 16236840)
Arch Iran Med. 2020 May 01;23(5):289-295. (PMID: 32383612)
Lancet Respir Med. 2014 Apr;2(4):267-76. (PMID: 24717623)
BMJ Open. 2016 Oct 14;6(10):e012823. (PMID: 27742632)
Br J Gen Pract. 1996 May;46(406):277-81. (PMID: 8762742)
Chang Gung Med J. 2010 Sep-Oct;33(5):515-23. (PMID: 20979702)
Thorax. 2007 Dec;62(12):1058-63. (PMID: 17666437)
COPD. 2016 Jun;13(3):333-8. (PMID: 26701201)
Thorax. 1971 Sep;26(5):555-71. (PMID: 5134057)
Thorax. 2003 Apr;58(4):322-7. (PMID: 12668795)
BMJ. 2012 Apr 17;344:e2502. (PMID: 22511302)
Acta Med Hist Adriat. 2013;11(1):101-12. (PMID: 23883087)
Can Respir J. 2007 Sep;14 Suppl B:5B-32B. (PMID: 17885691)
Can Respir J. 2001 Nov-Dec;8(6):421-6. (PMID: 11753455)
J Allergy Clin Immunol. 2006 Dec;118(6):1226-33. (PMID: 17157651)
Drug Alcohol Depend. 2002 Oct 1;68(2):221-8. (PMID: 12234652)
Prim Care Respir J. 2012 Dec;21(4):377-83. (PMID: 22875144)
Arch Iran Med. 2017 Apr;20(4):205-210. (PMID: 28412823)
Clin Respir J. 2018 Jun;12(6):2110-2116. (PMID: 29436772)
BMJ. 2004 Jun 26;328(7455):1519. (PMID: 15213107)
Clin Respir J. 2022 Mar;16(3):208-215. (PMID: 35060332)
Poumon Coeur. 1976;32(3):127-30. (PMID: 951350)
Acad Emerg Med. 2007 Jan;14(1):6-14. (PMID: 17119187)
Arch Intern Med. 2007 Feb 12;167(3):221-8. (PMID: 17296876)
NPJ Prim Care Respir Med. 2020 Jan 14;30(1):4. (PMID: 31937808)
Monaldi Arch Chest Dis. 2002 Feb;57(1):65-8. (PMID: 12174705)
Curr Opin Pulm Med. 2001 Mar;7(2):43-61. (PMID: 11224724)
J Asthma. 1999 May;36(3):257-64. (PMID: 10350222)
Am J Epidemiol. 2018 Apr 1;187(4):647-655. (PMID: 29145581)
Allergy Asthma Proc. 2001 Sep-Oct;22(5):285-91. (PMID: 11715217)
Arch Pathol Lab Med. 1998 Aug;122(8):691-9. (PMID: 9701330)
N Engl J Med. 1998 Oct 22;339(17):1194-200. (PMID: 9780339)
BMC Public Health. 2019 Oct 21;19(1):1312. (PMID: 31638932)
Respirology. 2002 Sep;7(3):233-9. (PMID: 12153689)
Respir Care. 2002 Oct;47(10):1184-99. (PMID: 12354338)
فهرسة مساهمة: Keywords: Asthma; COPD; Cohort; Iran; Prevalence
المشرفين على المادة: 8008-60-4 (Opium)
تواريخ الأحداث: Date Created: 20231102 Date Completed: 20231103 Latest Revision: 20231104
رمز التحديث: 20231104
مُعرف محوري في PubMed: PMC10619218
DOI: 10.1186/s12890-023-02734-8
PMID: 37914995
قاعدة البيانات: MEDLINE
الوصف
تدمد:1471-2466
DOI:10.1186/s12890-023-02734-8